The cardiac Na ؉ /Ca 2؉ exchanger (NCX1) plays a major role in the extrusion of Ca 2؉ from cardiomyocytes. We studied the role of protein phosphorylation in the regulation of cardiac NCX1 using CCL39 stably overexpressing the canine cardiac NCX1 and rat neonatal cardiomyocytes. In both cell types, the NCX1 protein immunoprecipitated with a chicken anti-NCX1 antibody exhibited a significant basal phosphorylation that was further enhanced by treatment with endothelin-1, acidic fibroblast growth factor, phorbol 12-myristate 13-acetate, or okadaic acid. In contrast, calphostin C, K252a, or EGTA inhibited the phosphorylation. The phosphorylation occurred on two major tryptic phosphopeptides (P1 and P2) exclusively on serine residues. Evidence is presented suggesting that P2 was derived from an N-terminal half (amino acids 240 -475) of the central cytoplasmic domain of NCX1 and was phosphorylated directly by protein kinase C (PKC). The agents that increased NCX1 phosphorylation significantly enhanced both the forward and reverse modes of Na ؉ /Ca 2؉ exchange. This exchange activation exhibited a very good correlation with the NCX1 phosphorylation. In NCX1-transfected cells, PKC down-regulation following prolonged exposure to phorbol 12-myristate 13-acetate abolished the acidic fibroblast growth factor-induced activation of exchange activity. On the other hand, cell ATP depletion reduced the exchange activity and abolished the effects of the above agents on exchange activity. These results indicate that the cardiac NCX1 is upregulated by PKC-catalyzed phosphorylation. The cardiac NCX1 thus could play an important role in the previously reported negative inotropic actions of phorbol esters and other PKC-activating agents.
The Na ϩ /Ca 2ϩ exchanger catalyzes the electrogenic exchange of 3 Na ϩ for 1 Ca 2ϩ across the plasma membrane in many mammalian cells. In cardiac muscle, this exchanger is particularly important in that during each action potential it rapidly extrudes the Ca 2ϩ that has entered the cardiomyocytes via the sarcolemmal L-type Ca 2ϩ channels to trigger the release of Ca 2ϩ from the sarcoplasmic reticulum (SR) 1 (1, 2) . In addition, the Na ϩ /Ca 2ϩ exchanger has been shown to play a much greater role in the slow extrusion of Ca 2ϩ from cardiomyocytes during diastole or under resting conditions than the sarcolemmal Ca 2ϩ pump (1, 3) . The same exchanger, on the other hand, is capable of bringing Ca 2ϩ into cardiomyocytes during cardiac depolarization, although triggering the release of Ca 2ϩ from the SR is much less efficient than that via the L-type Ca 2ϩ channels (1, 4) . Thus changes in these Ca 2ϩ fluxes via the Na ϩ /Ca 2ϩ exchanger should influence significantly the level of SR Ca 2ϩ loading, which eventually determines the inotropic state of cardiac muscle.
The cardiac isoform of Na ϩ /Ca 2ϩ exchanger (NCX1) is a protein of 938 amino acids with 11 membrane-spanning segments and a large central hydrophilic loop that is considered to form a regulatory cytoplasmic domain (5, 6) . The isoforms isolated from many other tissues are highly homologous to the cardiac isoform, except for the diversity found in a region near the carboxyl end of the cytoplasmic domain, which is due to alternative splicing (7, 8) . In brain and skeletal muscle, an isoform that is a product of a different gene (NCX2) is also expressed (9) . Na ϩ /Ca 2ϩ exchange in cardiomyocytes is highly modulated by several cytosolic factors; it is activated by cytosolic Ca 2ϩ and MgATP (10) but is inhibited by cytosolic Na ϩ (11) , cytoplasmic H ϩ (12) , and ATP depletion (13, 14) . MgATP has been shown to modulate the regulation by cytosolic Ca 2ϩ and Na ϩ in excised membrane patches from cardiomyocytes (15, 16) . These regulatory effects of Ca 2ϩ , Na ϩ , H ϩ , and ATP depletion are thought to be mediated by the cytoplasmic domain of the exchanger, because they are abolished by treating the cytoplasmic surface of the exchanger with chymotrypsin (10, 12) or by deletion mutagenesis of the cytoplasmic domain (6, 14) . A recent study has further suggested that a high affinity site for the regulatory Ca 2ϩ is localized within a specific region (amino acids 371-508) of the cytoplasmic domain of the canine cardiac NCX1 (17, 18) .
Stimulation of Na ϩ /Ca 2ϩ exchange by MgATP could occur through its direct effect on the exchanger or through indirect mechanisms including protein phosphorylation. In the membrane patch measurements, such an ATP effect was neither mimicked by both nonhydrolyzable and hydrolyzable ATP analogues, nor inhibited by protein kinase inhibitors, nor en-* This work was supported by Grant-in-Aid 353 for Scientific Research on Priority Areas from the Ministry of Education, Science and Culture of Japan and by Special Coordination Funds Promoting Science and Technology (Encouragement System of COE) from the Science and Technology Agency of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ Present address: Biochemistry, Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo, Hokkaido 060, Japan.
¶ To whom correspondence and reprint requests should be addressed: Dept. of Molecular Physiology, National Cardiovascular Center Research Institute, Fujishiro-dai 5, Suita, Osaka 565, Japan. hanced by protein phosphatase inhibitor okadaic acid (15) , suggesting no direct effect of ATP or involvement of protein kinases. Consistent with these findings is a recent report that phosphorylation of cardiac NCX1 isoform was not detected in 32 P-labeled Chinese hamster ovary or COS cells that stably expressed the bovine cardiac NCX1 (14) . Thus there has been little information regarding the physiological mechanism(s) by which ATP regulates Na ϩ /Ca 2ϩ exchange in cardiomyocytes. In contrast to these findings, we have recently found that the aortic isoform of NCX1 is phosphorylated and concomitantly activated in response to growth factors or phorbol ester in primary cultures of rat aorta smooth muscle cells (19) . In addition, previous studies with invertebrate squid giant axons have provided strong evidence for the involvement of protein phosphorylation in the ATP-dependent stimulation of Na ϩ / Ca 2ϩ exchange, although direct evidence was lacking (20, 21) . In this study, we investigated whether the cardiac Na ϩ /Ca 2ϩ exchanger is regulated by protein phosphorylation. To facilitate analysis of this subject, we prepared CCL39 cells stably overexpressing the canine cardiac NCX1. Using these cells and primary cultures of rat neonatal cardiomyocytes, we show that Na ϩ /Ca 2ϩ exchange by the cardiac isoform of NCX1 is upregulated by PKC-dependent phosphorylation. Moreover, we suggest that PKC-catalyzed phosphorylation of the NCX1 protein at site(s) in the N-terminal half of the cytoplasmic domain may be involved at least in part in such NCX1 activation.
EXPERIMENTAL PROCEDURES
Cell Cultures-CCL39 cells (ATCC) and NCX1-transfected cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 7.5% heat-inactivated fetal calf serum, 50 units/ml penicillin, and 50 g/ml streptomycin. Primary cultures of neonatal cardiomyocytes were prepared from Wistar rats by the method described previously (22) . Cardiomyocytes were used after 3-5 days of culture.
Construction and Stable Expression of NCX1-The 3-kilobase SmaIHindIII fragment of the canine cardiac NCX1 cDNA (7) was inserted into the mammalian expression vector pKCRH (23) to produce pKCRH-NCX1. CCL39 cells (5 ϫ 10 5 cells/100-mm dish) were transfected with 20 g of pKCRH-NCX1 or pKCRH vector by the calcium phosphate precipitation method. Fifty cell clones were isolated from the colonies grown in the medium containing 500 g/ml G418 and tested for Na ϩ / Ca 2ϩ exchange activity and NCX1 protein expression (cf. Fig. 1 ). Single cell clones expressing the highest levels of NCX1 were chosen and used for experiments.
Preparation of MBP Fusion Protein-DNA fragments corresponding to amino acids 240 -737 and 240 -475 (5) of the cytoplasmic domain of canine cardiac NCX1 were amplified by polymerase chain reaction with pKCRH-NCX1 as a template using the following primers: for sense, 5Ј-ATGATATCATCGAGCACGAAGGAGAC-3Ј; for antisense, 5Ј-AT-GTCGACTCAGGAGGGCAGCTTCTCCTC-3Ј (for amino acids 240 -737) and 5Ј-ATGTCGACTTACAGGATGCCGTCTTCTGA-3Ј (for amino acids 240 -475). After restriction enzyme digestion, DNA fragments were inserted downstream of the malE gene (StuI-SalI sites) in pMal-c vector (New England BioLabs). Soluble fusion protein was purified from transformed Escherichia coli (TB1 strain) according to the manufacturer's protocol.
Antibody Production-A chicken polyclonal antibody was raised against a mixture of nine peptides from predicted extracellular loops of rat NCX1 (7), which were chemically synthesized in multiple antigen peptide form (Iwaki Glass Co.). The amino acid sequences of these peptides are as follows; DTEAETGGNETTECTGSYYC, ETTECTG-SYYCKKGVILPIW, KKGVILPIWEPQDPSFGDK, CGHNFTAGDLGP-STI, SVSSPGVG, PPTEYWNG, GTSVPDTFASKVAATQDQYA, VAATQDQYADASIGNVTGSN, and RRRPEIGGELGGPRTAK. These peptides (300 g each) were injected subcutaneously into the legs of an outbreed white leghorn chicken (Babcock B300) with complete and then with incomplete Freund's adjuvant at 10-day intervals. After the titer was sufficiently increased, IgY was purified from egg yolk (24) .
Immunoprecipitation, Phosphopeptide Mapping, and Phosphoamino Acid Analysis-Immunoprecipitation, phosphopeptide mapping, and phosphoamino acid analysis were carried out as described previously (19) , except that anti-IgY-Agarose (Promega), instead of protein ASepharose, was used. ] i in monolayer cultured cells was measured using Fura-2 as a fluorescent Ca 2ϩ indicator as described previously (25) . Cell Na ϩ content was measured by equilibrating cells with BSS containing 22 Na ϩ (740 KBq/ml), and [Na ϩ ] i was calculated by assuming 5 l of cell water/mg of protein (26) .
Measurement of ATP Content-For depletion of cell ATP, cells (5 ϫ 10
6 cells/35-mm dish) were incubated for 20 min in a glucose-free Na ϩ -loading medium supplemented with 10 mM 2-deoxy-D-glucose and 2.5 g/ml oligomycin. For ATP measurement, cells were extracted with ice-cold 8% perchloric acid, and the extract was then neutralized with 1 M Tris. The ATP concentration was assayed by the luciferin-luciferase method (ATP bioluminescence kit, Boehringer Mannheim).
Other Procedures-Preparation of the membrane fraction, SDS-PAGE, and immunoblotting were performed essentially as described (27) . CaMKII was purified from rat brain as described previously (28) . Protein was measured with the BCA protein assay reagent (Pierce) with BSA as a standard.
Statistical Analysis-Results are expressed as the means Ϯ S.E. of 3 or 4 independent determinations. Differences were analyzed by oneway analysis of variance followed by Dunnett's test. Statistical significance was assumed at a p value of Ͻ0.05.
Materials-Purified PKCs (a mixture of ␣, ␤, and ␥ isoforms) were obtained from Seikagaku Co. The ␣-isozyme of PKG was purchased from Promega. Purified MAP kinase (p44) was from Upstate Biotechnology Inc. The catalytic subunit of PKA, cGMP, BSA (fatty acid-free), monensin, ouabain, verapamil, PMA, oligomycin, 1,2-dioleoyl-rac-glycerol, and phosphatidylserine were from Sigma. Inc. Fura-2/acetoxymethyl ester was from Dojindo Laboratories. Endothelin-1 was from the Peptide Institute. Purified MBP was purchased from New England BioLabs. All other chemicals were of analytical grade.
RESULTS
Expression of Cardiac NCX1-CCL39 cell clones expressing the highest levels of canine cardiac NCX1 were selected from G418-resistant colonies as described under "Experimental Procedures." (Fig. 1B) . The expression level of NCX1 protein in transfected cells was comparable with that in rat neonatal cardiomyocytes, which was more than 15-fold higher than that in nontransfected cells (Fig. 1B) . Thus we produced stable transfectants with a high NCX1 expression. As for the decrease of 45 Ca 2ϩ uptake in nontransfected cells upon replacement of external Na ϩ with K ϩ , we do not know the mechanism. However, a similar result was reported previously in nontransfected Chinese hamster ovary cells (29) .
Phosphorylation of Cardiac NCX1-We examined the phosphorylation of NCX1 protein in transfected cells and cardiomyocytes. The NCX1 protein was isolated by immunoprecipitation with the chicken anti-NCX1 antibody from lysates of cells that had been labeled with [ 32 P]orthophosphate and subsequently treated with various agents. The NCX1 protein exhibited a significant basal phosphorylation in transfected cells as well as in cardiomyocytes (Fig. 1C, Control) . We also detected a very slight phosphorylation of the same protein band even in nontransfected cells (Fig. 1C, CCL39) . NCX1 phosphorylation in transfected cells increased to 154 Ϯ 5, 146 Ϯ 6, or 149 Ϯ 9% of control, respectively, when cells had been exposed for 20 min to 0.3 M PMA, 1 M okadaic acid, or 30 ng/ml aFGF. In contrast, treatment of transfected cells with 30 M K252a, a nonspecific protein kinase inhibitor, or 3 M calphostin C, a specific PKC inhibitor, resulted in reduction of phosphorylation to 28 Ϯ 2 or 41 Ϯ 2% of control, respectively (Fig. 1D) . Removal of external Ca 2ϩ by EGTA also reduced phosphorylation to 63 Ϯ 2%. Essentially the same patterns of increase and decrease in NCX1 phosphorylation relative to the basal level were observed in cardiomyocytes, 115 Ϯ 4% with 0.3 M PMA, 118 Ϯ 3% with 1 M okadaic acid, 122 Ϯ 5% with 0.1 M endothelin-1, 38 Ϯ 2% with 30 M K252a, 35 Ϯ 3% with 3 M calphostin C, and 63 Ϯ 4% with 4 mM EGTA (Fig. 1, C and D) .
To characterize the phosphorylation sites in NCX1 protein, we performed two-dimensional tryptic phosphopeptide mapping ( Fig. 2A) . Tryptic digestion of protein was isolated by immunoprecipitation and subsequent SDS-PAGE. A, the NCX1 protein eluted from gels was digested with trypsin and subjected to two-dimensional phosphopeptide mapping. The right bottom panel schematically shows the location of phosphopeptides and direction of peptide migration (arrow). B, the NCX1 protein eluted from gels was subjected to tryptic digestion and acid hydrolysis, and the resultant phosphoamino acids were analyzed by thin layer electrophoresis. P-Ser, P-Thr, and P-Tyr represent the positions of phosphoserine, phosphothreonine, and phosphotyrosine, respectively. 
Phosphorylation of Cardiac Na
from both transfected cells and cardiomyocytes under basal conditions generated two major phosphopeptides (P1 and P2), suggesting that NCX1 phosphorylation occurred at more than one site. Some minor spots observed may represent partially digested phosphopeptides. Exposure of transfected cells to 0.3 M PMA ( Fig. 2A) or 30 ng/ml aFGF (data not shown) for 20 min resulted in a significant increase in 32 P label incorporation into both P1 and P2. Phosphoamino acid analysis revealed that NCX1 phosphorylation occurred exclusively on serine residues in both cell types (Fig. 2B) .
Phosphorylation of Fusion Protein Containing NCX1 Cytoplasmic Domain-To obtain information of the protein kinase(s) involved in NCX1 phosphorylation in intact cells, MBP fusion protein containing part or the entire cytoplasmic domain of canine cardiac NCX1 were treated with various serine/threonine protein kinases as described under "Experimental Procedures." The MBP fusion protein containing the entire cytoplasmic domain (amino acids 240 -737) was visualized as a doublet on a Coomassie Brilliant Blue-stained gel (Fig. 3A,  CBB, FP) , suggesting proteolysis. Among the five protein kinases tested, PKC, CaMKII, and PKA markedly phosphorylated the fusion protein, although these kinases did not significantly phosphorylate MBP itself (Fig. 3A) . Thus, the cytoplasmic domain of canine cardiac NCX1 serves as a good substrate for these protein kinases in vitro.
Two-dimensional tryptic phosphopeptide mapping revealed that several phosphopeptides were generated from the fusion protein phosphorylated by either PKC or CaMKII, whereas only one major phosphopeptide was obtained from PKA-phosphorylated fusion protein (Fig. 3B) . One of peptides from the PKC-phosphorylated fusion protein migrated in the same way as P2, a major phosphopeptide from cardiac NCX1 phosphorylated in vivo (Fig. 3B) . This was confirmed by mapping a mixture of phosphopeptides generated from NCX1 proteins phosphorylated in vivo and in vitro. In contrast, phosphopeptide maps of neither CaMKII-phosphorylated nor PKA-phosphorylated fusion proteins contained peptides corresponding to P1 and P2 from NCX1 protein phosphorylated in vivo. PKG and MAP kinase, on the other hand, did not phosphorylate the fusion protein (data not shown).
We then examined whether PKC also phosphorylates the MBP fusion protein containing an N-terminal half (amino acids 240 -475) of the cytoplasmic domain. By phosphopeptide mapping, we found that this fusion protein was also phosphorylated by PKC and subsequently generated several phosphopeptides that included a phosphopeptide corresponding to P2 (data not shown). These results strongly suggest that the phosphorylation site that generates P2 exists in amino acids 240 -475 of the cytoplasmic domain of the canine cardiac NCX1 and that phosphorylation of this site in intact NCX1-expressing cells is effected directly by PKC.
Regulation of 45 Ca 2ϩ Uptake into Na ϩ -loaded Cells-We examined the effects of PMA and other agents on 45 Ca 2ϩ uptake into Na ϩ -loaded NCX1-transfected cells and Na ϩ -loaded cardiomyocytes (Fig. 4) . Cell Na ϩ loading and pretreatment with these agents was performed simultaneously for 20 min. During this period, [Ca 2ϩ ] i , as monitored by Fura-2 fluorescence, was kept at 70 -100 nM by the use of a Na ϩ -loading medium containing low Ca 2ϩ (0.1 mM) (see "Experimental Procedures"). The final [Na ϩ ] i reached in Na ϩ -loaded transfected cells treated with these agents were similar, 81 Ϯ 2, 76 Ϯ 6, and 75 Ϯ 5 mM in control, 0.3 M PMA-, and 10 M calphostin Ctreated cells, respectively.
PMA and okadaic acid dose-dependently stimulated the rate of 45 Ca 2ϩ uptake into NCX1-transfected cells and cardiomyocytes, whereas calphostin C and K252a caused dose-dependent decreases in both cell types (Fig. 4A) . It should be noted that the stimulations by PMA and okadaic acid were greater in NCX1-transfected cells than in cardiomyocytes, whereas the opposite was true for the inhibitions by calphostin C and K252a. This difference in response is probably attributable to a higher basal level of NCX1 phosphorylation in cardiomyocytes as compared with transfected cells. aFGF also significantly stimulated 45 Ca 2ϩ uptake into NCX1-transfected cells (Fig.  4B) . Such aFGF-induced stimulation was decreased markedly or abolished, respectively, in cells preincubated with EGTA during the aFGF treatment or in cells pretreated with PMA for 24 h. In cardiomyocytes, on the other hand, 0.1 M endothelin-1 also increased the rate of 45 Ca 2ϩ uptake to 122 Ϯ 5% of control. We studied the relationship between the intensity of NCX1 phosphorylation and the observed rate of 45 Ca 2ϩ uptake in NCX1-transfected cells and cardiomyocytes that had been exposed to all these stimulatory and inhibitory agents (Figs. 1  and 4 , and data not shown). These parameters were normalized by the basal levels of phosphorylation and 45 Ca 2ϩ uptake, respectively, in each cell type. As shown in Fig. 5 , there is an excellent correlation between these two parameters, which is compatible with the notion that NCX1 phosphorylation stimulates Na ϩ /Ca 2ϩ exchange activity in transfected cells as well as in cardiomyocytes.
We next determined the effects of PMA and calphostin C on the external Ca 2ϩ concentration dependence of the rate of 45 Ca 2ϩ uptake into Na ϩ -loaded transfected cells (Fig. 6A) . 2ϩ uptake decreased to 55 Ϯ 2% of control (Fig.   7 ), whereas NCX1 phosphorylation decreased to 73 Ϯ 4%. Interestingly, PMA, calphostin C, or K252a did not affect Na
Ca 2ϩ uptake significantly, but okadaic acid partially reversed the inhibition (Fig. 7) . These agents by themselves did not influence the ATP content of NCX1-transfected cells (data not shown).
Effect of PMA on Na -free uptake media (see "Experimental Procedures"). B, indicated concentrations of NaCl were added to the Na ϩ -free uptake medium (replacing choline chloride with equimolar NaCl). ] i decreased to about 0.7 M after the Na ] i , which eventually reached a low steady state level (Fig. 8) . In contrast, addition of choline chloride did not accelerate the [Ca 2ϩ ] i decline. The [Ca 2ϩ ] i decline evoked by Na ϩ o was significantly faster in PMA-treated than in nontreated cardiomyocytes (Fig. 8, inset) . The steady state [Ca 2ϩ ] i was also lower in PMA-treated cells.

DISCUSSION
In this study, we successfully produced CCL39 cells stably expressing the cardiac isoform of NCX1 to a level comparable to that in neonatal cardiomyocytes. The cardiac NCX1 protein in transfected cells and cardiomyocytes exhibited significant levels of phosphorylation under resting conditions (Fig. 1) . NCX1 phosphorylation was increased when these cells were treated with phorbol ester, okadaic acid, an inhibitor of protein phosphatases type 1 and type 2A, and physiological ligands such as aFGF and ET-1 that produce 1,2-diacylglycerol through the activation of phospholipase C (32) (Fig. 1) . In contrast, phosphorylation was inhibited markedly by treatment with calphostin C, K252a, or extracellular EGTA (Fig. 1) . Phosphorylation occurred exclusively on serine residues (Fig. 2) . Tryptic phosphopeptide mapping revealed that two major phosphopeptides (P1 and P2) were generated from the NCX1 proteins derived from 32 P-labeled untreated as well as PMA-treated transfected cells, suggesting that phosphorylation occurred at more than one site in vivo. These results suggest that phosphorylation of the cardiac NCX1 in both transfected cells and cardiomyocytes occurred via a PKC-dependent pathway.
To map the phosphorylation sites more closely, we examined whether several purified serine/threonine protein kinases in vitro phosphorylate the MBP fusion protein containing the cytoplasmic domain of cardiac NCX1 (Fig. 3 and see "Results") . PKC, CaMKII, and PKA, but not PKG and MAP kinase, extensively phosphorylated the fusion protein containing the entire NCX1 cytoplasmic domain (amino acids 240 -737). Phosphopeptide mapping revealed that only the fusion protein that had been phosphorylated by PKC generated a phosphopeptide corresponding to P2 (Fig. 2) . Furthermore, using the same technique, we obtained evidence that P2 was localized within an N-terminal half (amino acids 240 -475) of the cytoplasmic domain, which contains several candidate phosphorylation site sequences for PKC (5) . We thus conclude that in intact cells, PKC directly phosphorylates a site(s) in P2 within amino acids 240 -475 of the cardiac NCX1. This region partly overlaps the high affinity Ca 2ϩ regulatory domain (amino acids 371-508) that is required for the secondary Ca 2ϩ activation of the cardiac NCX1 (17, 18) . This raises the intriguing hypothesis that the phosphorylation may occur within the high affinity Ca 2ϩ binding site and thus modulate the Ca 2ϩ -dependent activation of cardiac NCX1. As for P1, no information is currently available concerning its location.
We found that PMA, okadaic acid, aFGF, or ET-1 significantly enhanced Na ϩ i -dependent 45 Ca 2ϩ uptake into NCX1-transfected cells or cardiomyocytes, whereas calphostin C, K252a, and external EGTA markedly inhibited 45 Ca 2ϩ uptake in these cells (Fig. 4) . In addition, the aFGF-induced activation of Na ϩ i -dependent 45 Ca 2ϩ uptake into NCX1-transfected cells was almost completely inhibited after prolonged exposure to PMA, a procedure known to cause down-regulation of PKC (Fig. 4) . The Na ] i reduction which monitors the forward mode of Na ϩ /Ca 2ϩ exchange (Fig. 8) . Thus PKC is involved in up-regulation of both modes of Na ϩ /Ca 2ϩ exchange by the cardiac NCX1.
In NCX1-transfected cells, PMA and calphostin C changed the V max value in Ca (Fig. 6A) . Furthermore, these agents did not affect the IC 50 value for Na ] i during cell Na ϩ loading by the use of low Ca 2ϩ (0.1 mM) in the Na ϩ -loading medium. On the basis of the observed linear relationship between the two parameters, we predict that the exchange activity of the NCX1 is already elevated in unstimulated cells due to its relatively high basal phosphorylation and that about 50% of the basal exchange activity still remains in the complete absence of NCX1 phosphorylation. The latter suggests that the extent of stimulation of the exchange activity by activating agents could be much larger than the apparent one, reaching a high value of about 3-fold with 0.3 M PMA (Fig. 5) . It should also be pointed out that MgATP-dependent stimulation of the cardiac NCX1 activity under patch conditions was suggested not to involve protein kinases (15) , as briefly discussed in the Introduction. One possibility compatible with both the present and this previous result could be that phosphorylation of an unidentified ancillary factor(s) missing from the excised membrane patches, but not the direct phosphorylation of the NCX1 protein, is required for the PKC-dependent regulation of the NCX1 activity. Clarification of this point requires further study.
ATP depletion reduced Na ϩ /Ca 2ϩ exchange activity in NCX1-transfected cells by up to 45% (see "Results"), which is consistent with previous data obtained with other cell types (13, 14, 29) . Interestingly, in transfected cells whose ATP content had decreased to about 6% of control cells, phorbol ester, calphostin C, and K252a did not affect the Na ϩ /Ca 2ϩ exchange activity (Fig. 7) , indicating that ATP depletion abolishes the phosphorylation-dependent regulation of cardiac NCX1. We tested the hypothesis that the inhibition was due to dephosphorylation of NCX1. In ATP-depleted cells, however, NCX1 phosphorylation decreased only by 23% (see "Results"), and okadaic acid, which was added to the ATP-depletion medium together with metabolic inhibitors, failed to fully prevent the inhibition of the NCX1 activity by ATP depletion (Fig. 7) . Thus ATP depletion inhibits the cardiac NCX1 activity mainly by mechanism(s) other than the dephosphorylation, which might include the breakdown of the actin cytoskeleton (14) and cell acidification (31) . However, since okadaic acid did reverse the ATP depletion-dependent NCX1 inhibition slightly but significantly, it appears that the dephosphorylation was partially responsible for the observed inhibition (Fig. 7) .
Finally, we briefly discuss the role of the Na ] i to a low steady state level (Fig. 8) . PMA reduced diastolic [Ca 2ϩ ] i in normal beating cardiomyocytes and also accelerated the Na ] i decline in cardiomyocytes that had been placed in Na ϩ -free medium (Fig. 8) . These findings are consistent with many previous studies that demonstrated that phorbol ester and synthetic diacylglycerol, and also ␣-adrenergic agonists and angiotensin II under certain conditions, exert significant depressive effects on the contractile function in a variety of cardiac preparations (33) (34) (35) (36) (37) and reduce diastolic [Ca 2ϩ ] i as well as Ca 2ϩ transient peaks in isolated perfused heart (36) and isolated adult cardiomyocytes (35, 37) . Since phorbol ester and exogenous diacylglycerol do not enhance phosphorylation of phospholamban in the sarcoplasmic reticulum in intact cardiomyocytes (38, 39) , increased Ca 2ϩ extrusion across the sarcolemma is the most likely mechanism for the observed decrease in [Ca 2ϩ ] i . Thus, as the principal mechanism for extrusion of Ca 2ϩ from cardiomyocytes (see Introduction), the Na ϩ /Ca 2ϩ exchanger should play an important role in the negative inotropic effect induced by phorbol ester and other agents.
